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o  begin  such  an  engrossing  editorial  subject,  an  accurate
nd  conceptually  universal  deﬁnition  of  the  prevention  of
ardiovascular  disease  (cardiovascular  disease)  will  be  con-
idered.  Accordingly,  the  deﬁnition  adopted  by  the  6th  Joint
ask  Force  of  the  European  Society  of  Cardiology1 will  be
ssumed.  This  body  deﬁnes  it  as  a  set  of  coordinated  actions
imed  at  a  population  or  an  individual,  with  the  purpose
f  eliminating  or  minimizing  its  impact  and  the  disabilities
ssociated  with  it.2
When  this  deﬁnition  is  contextualized,  it  is  clear  that  in
ight  of  a  disease  that  is  still  today  the  world  leader
n  morbidity  and  mortality,  prevention  becomes  a priority,
specially  when  tendencies  towards  a  decline  in  coronary
isease  have  been  observed  since  the  80s  in  nations  and
egions  with  a  high-income  population.3 This  guideline  is
irectly  related  to  the  preventive  measures  which  were
uccessfully  put  into  effect,  including  the  enacting,  in
any  countries,  of  anti-tobacco  laws,  but  is  not  seen
n  nations  such  as  ours,  where  we  continue  to  see  a  progres-
ive  and  concerning  escalation  in  the  incidence  of  obesity,
edentarism,  and  diabetes  mellitus,  in  terms  of  modiﬁable
ardiovascular  risk  factors.  No  less  alarming  is  the  scant
ffectiveness  in  achieving  goals  in  the  treatment  of  highDOI of original article:
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pen access article under the CC BY-NC-ND license (http://creativecommrequency  pathologies  in  our  context,  such  as  arterial  hyper-
ension,  hypercholesterolemia  and  diabetes  itself,  due  to  a
ack  of  compliance  for  multiple  reasons.
An  evaluation  of  the  direct  causes  of  these  tenden-
ies  shows  that  the  ﬁrst  circumstance  causing  the  ongoing
ise  in  chronic  noncommunicable  diseases  is  modern  life
tyles,  which,  beginning  with  the  process  of  industrializa-
ion,  changed  the  course  of  the  world,  and  which,  while
roviding  a  different  quality  of  life,  are  also  taking  their
oll.
The  advent  of  automation,  assisted  mobility,  and  the
nternet  created  a  completely  sedentary  environment  lead-
ng  to  an  excessive  caloric  intake  which  is  difﬁcult  to  control,
esulting  in  increased  obesity  as  a  prevalent  disease  world-
ide,  and  bringing  with  it  all  its  adversities.4 Within  these
endencies,  it  is  even  more  concerning  to  see  how  obesity
as  been  concentrated  in  the  very  young.
Joined  with  these  changes  is  the  ever  greater  capacity
f  having  health  care  treatment  facilities  in  our  commu-
ities,  and  great  technological  advances  which,  applied  to
edicine,  have  resulted  in  an  increased  life  expectancy  and
ltimately  a  very  signiﬁcant  one  in  those  over  65  years  of
ge,  which  leads  to  having  people  with  greater  morbidities
nd  noncommunicable  chronic  diseases  with  a  high  eco-
5omic  impact  on  the  health  system  of  any  country.
In  this  scenario,  it  is  pertinent  to  come  back  to  the
rticle:  ‘‘ever  too  soon,  never  too  late  for  prevention’’,
ublished  in  2014  in  the  Revista  Espan˜ola  de  Cardiología,
dad Colombiana de Cardiolog´ıa y Cirug´ıa Cardiovascular. This is an
ons.org/licenses/by-nc-nd/4.0/).
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which  gives  an  overview  of  primordial  and  primary  preven-
tion  across  an  individual’s  life  span.  The  authors  describe
novel  strategies  for  achieving  healthy  life  habits  which  will
prevent  the  adoption  of  cardiovascular  risk  factors;  in  other
words,  practicing  primordial  prevention  and  creating  inter-
ventions  designed  to  modify  cardiovascular  risk  factors  in
order  to  avoid  the  initial  cardiovascular  event.6
In  the  local  context,  we  cardiologists  are  faced  with  a
scenario  that  could  well  be  summarized  as  follows:
1.  Life  habits  which  make  our  populations  susceptible  to
noncommunicable  chronic  diseases:  high  calorie  intake
leading  to  obesity,  internet  penetration  and  facili-
tated  mobility  resulting  in  sedentarism,  and  the  use  of
cigarettes  and  highly  addictive  substances.
2.  An  increase  in  type  2  diabetes,  secondary  to  these  life
habits.
3.  A  change  in  demographic  tendencies,  with  a  signiﬁcant
increase  in  the  population  over  the  age  of  65.
4.  Lack  of  adherence  to  pharmacological  treatments  and  to
heart  healthy  life  habits.
Based  on  the  previous  scenario,  Colombia’s  health  sys-
tem  has  been  developing  and  has  begun  to  implement  a
more  comprehensive  and  possibly  more  effective  vision  of
noncommunicable  chronic  disease  management,  including
cardiovascular  disease  and  diabetes,  with  a  plan  for  how  to
maintain  compliance  with  the  program,  creating  a  sense  of
belonging,  and  providing  the  patient  with  more  knowledge
of  his/her  own  disease  and  what  self-care  implies.
Current role of the cardiologist in the
challenge taken on by our health care system
The  work  group  is  generally  made  up  of  a  medical  specialist
accompanied  by  an  expert  primary  care  physician,  a  nurse,
psychologist,  pharmacist,  nutritionist  and  a  cardiac  reha-
bilitation  program.  This  work  team  recognizes  the  need  to
work  with  the  knowledge  provided  by  the  cardiologist  and
his/her  expert  primary  physician,  together  with  a  positive
environment  generated  by  the  vision  of  positive  cardiovas-
cular  health  which  arises  from  the  integration  of  positive
psychology  and  preventive  cardiology.7
With  regard  to  the  compliance  strategy,  which  is  a  funda-
mental  point  in  secondary  prevention,  (as  shown  by  Freeman
et  al.  in  their  article,  where  it  had  an  impact  on  80%  of
the  ﬁnal  outcomes  in  post-myocardial  infarction  patients),
a  minimum  of  40%  of  compliance  should  be  maintained  in
order  to  retain  the  impact,8 a  situation  which  is  reinforced
by  the  group  nurse  and  pharmacist.
Likewise,  the  nutritional  aspect,  according  to  the
National  Institute  for  Health  and  Care  Excellence,  ‘‘NICE’’),
speaks  of  how  mortality  can  be  impacted.  Coronary  disease
could  be  cut  in  half  with  just  modest  reductions  in  cardio-
vascular  risk  factors,  since  it  suggests  that  by  establishing
eight  dietary  priorities,  deaths  due  to  cardiovascular  dis-
ease  could  also  be  lowered  by  half,9 thus  becoming  another
fundamental  element  in  the  comprehensive  management  of
the  cardiovascular  patient.
Likewise,  rehabilitation  and  exercise  medicine  enter  the
picture,  under  the  supervision  of  sports  medicine  physicians,n  program  e17
hysiatrists,  and  exercise  specialists  who  propose,  (based
n  the  work  of  Professor  Antikainen  recently  revealed  at
he  European  Congress  on  cardiology  in  Rome:  Leisure  time
hysical  activity  reduces  the  risk  of  cardiovascular  death
nd  an  acute  CVD  event  also  among  older  adults),  that  mod-
rate  physical  activity  reduces  the  risk  of  a  cardiovascular
vent  by  more  than  30%  and  that  high  levels  of  exercise  may
chieve  greater  risk  reductions.10 In  this  way,  an  exceptional
ork  group  is  formed  which  manages  to  have  an  impact
n  disease  through  the  use  of  simple  and  cost-efﬁcient
esources.
As leader,  the  cardiologist  should  be  part  of  the  whole
rocess,  administer  the  resources  and  direct  each  line  of
are.  In  order  to  carry  out  these  activities  he/she  should
e  familiar  with,  and  make  a  greater  commitment  to,
he  comprehensive  models,  giving  positive  feedback  and
irecting  them  on  behalf  of  health  care  institutions,  health
are  administration  institutions,  the  health  group  and  the
atient.
It  is  a  commitment,  and  practically  an  obligation,  to  the
atient  for  the  cardiologist  to  facilitate  and  implement  this
ystem,  in  order  to  impart  a  true  concept  of  health  with
hich  disease  may  be  controlled  by  providing  basic  and  spe-
ialized  health  care.  This  health  care  includes  a  degree  of
ducation  which  is  considered  secondary  prevention,  where
he  primary  objective  is  to  seek  drug  compliance  and  a
reservation  of  healthy  life  habits  through  providing  support
n  supervised  exercise,  as  well  as  motivation  to  acquire  the
abit  of  frequent  attendance  at  the  established  program.
amily  or  primary  caregiver  support  of  the  patient  is  not
eft  out,  as  they  also  receive  education,  in  this  way  closing
he  complete  cycle  with  a  little  prevention.
All  these  actions  are  measured  according  to  their
mmense  impact  on  morbidity  and  mortality  in  patients  with
ardiovascular  disease.
In summary,  the  clinical  cardiologist  is  called  to  action
s  leader  and  possessor  of  knowledge,  and  to  create  an
ppropriate  work  team  which  shares  those  same  interests.
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